Global Orthopedic Bone Cement Market - 2022-2029

Market Overview

Orthopedic Bone Cement Market was valued at USD million in 2021. It is forecasted to reach USD million by 2029, growing at a CAGR of 5.9% during the forecast period (2022-2029).

The orthopedic bone cement is used to anchor artificial joints like hip joints, knee joints, and shoulder and elbow joints. The bone cement fills the free space between the bones and plays the important role of an elastic zone. Bone cement is a chemical made from polymethyl methacrylate or PMMA. There is a lack of inherent adhesive properties; however, it depends closely on the intertwining between the prosthesis and the irregular bone surface. Bone cement is commercially obtainable as Glass Polyalkenoate (ionomer) cement (GPC) and Calcium Phosphate Cement (CPC). Certain factors leading the market growth include the rising geriatric population, the increasing R&D expenditure, and untapped opportunities in emerging markets. However, the side effects associated with orthopedic bone cement will hamper the market growth during the forecast period.

Market Dynamics: Rising geriatric population worldwide drives market growth of orthopedic bone cements market

The global geriatric population is growing significantly. In the past few years, the aging population of the United States increasing. For instance, in 2020, about 16.9 percent of the American population was 65 years old or over, a figure which is expected to reach 22 percent by 2050. In addition birth rate in the United States has been falling over the last 20 years. California and Florida are the dominant states in the United States. According to World Health Organization's estimated data, by 2030, 1 in 6 people in the world will be aged 60 years or above. The share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world's population of people aged 60 years and older will double. The aging population above 80 or older is expected to triple between 2020 and 2050 to reach 426 million.

Also, the increasing number of road accident cases drives the market growth in the forecast period. Road accidents are constantly increasing, especially in emerging nations, such as India. Moreover, the rising number of natural disasters is further encouraging the number of surgical procedures. These factors have substantially increased the number of orthopedic surgeries over the years, consequently advancing the growth of the orthopedic bone cement market.

Market Segmentation: Arthroplasty lead the market throughout the forecast period

Based on the application, the orthopedic bone cement market has been classified into arthroplasty, kyphoplasty, veteroplasty, and dental implants.

The arthroplasty segment led the overall market with a share in 2019. It is an orthopedic surgical procedure in which the articular surface of a musculoskeletal joint is restored, renovated, or rearranged by osteotomy or some other similar procedure. Among all other types of application, the treatment rate with arthroplasty is relatively high, owing to which it can be determined that the orthopedic bone cement market is driven by arthroplasty application.

Based on the end-user, the orthopedic bone cement market has been classified into hospitals & clinics and ambulatory surgical centers. The hospitals & clinics segment contributed a significant share to the global orthopedic bone cement market in 2022. The large patient pool accommodated by the hospitals and their control in emerging and low-income countries is projected to drive demand for orthopedic bone cement. These are certainly major factors that can be accredited to its high revenue share in the forecast period. However, the shifting business trend from hospitals to specialty clinics is expected to inhibit the growth of this segment during the forecast period.

Geographical Penetration: North America is the dominating region during the forecast period.

Based on geography, the study analyzes the orthopedic bone cement market in the global market, including North America, South America, Europe, Asia-Pacific, and the Middle East & Africa.

North America dominated the global orthopedic bone cement market with the largest share in value and volume globally, followed by Europe and the Asia Pacific. The US dominated the North American orthopedic bone cement market in 2019. The local presence of several major market players with an established distribution channel is one of the key factors driving the regional growth in the market. Moreover, the favorable reimbursement policies aligned with the orthopedic surgical procedures in the country are another factor responsible for the dominance of the US in the orthopedic bone cement market.

Moreover, Asia Pacific is expected to project the fastest orthopedic bone cement market growth rate during the forecast period. China dominates the market, whereas India is estimated to exhibit considerable growth in the Asia Pacific orthopedic bone cement market during the forecast period. The Asia Pacific is anticipated to exhibit huge growth due to increasing per capita income, growing medical tourism, and rising healthcare spending by the government.

Competitive Landscape:

The orthopedic bone cement market is highly competitive, owing to the large presence of orthopedic bone cement brands. The key orthopedic bone cement players include DePuy Synthesis, Stryker Corporation, DJO Global, Smith & Nephew, Cook Medical, Surbiton LABORATORIOS SL S.A, Kingyork Group, SCANOS, Teknimed SA, Zimmer Biomet Holdings Inc The crucial players are adopting new product launches and expansion strategies for global growth in the orthopedic bone cement market. In December 2021, DePuy Synthes Announced the Acquisition of OrthoSpin. OrthoSpin developed and manufactured an automated strut system in conjunction with DePuy Synthes MAX FRAME Multi-Axial Correction System, an external ring fixation system. DePuy Synthes is an orthopedic company of the Johnson & Johnson Medical Devices Company. In April 2021, DJO, a leading global provider of medical technologies to get and keep people moving, Acquired privately held MedShape, Inc. The acquired business portfolio includes innovative devices for fracture fixation, joint fusion and soft tissue injury repair that utilize biomaterial technologies designed to improve patient outcomes. In June 2022, Stryker announced a definitive agreement to acquire Vocera Communications. This acquisition issued outstanding shares of common stock of Vocera Communications, Inc. for $79.25 per share. Vocera has a leading platform in the digital care coordination and communication category. The importance of this growing segment has continued to expand throughout the pandemic as it aims to reduce cognitive overload for caregivers and enables them to deliver the best patient care possible.

COVID-19 Impact: Positive impact on the global orthopedic bone cements market.

Worldwide, COVID-19 has affected the daily life of people, businesses, manufacturers, and even the healthcare sector. COVID-19 has affected the orthopedic field by which doctors are not adequately concentrating on their regular patients. During the pandemic, there is a shortage of patients, doctors, support staff, medicines, and other equipment and devices. Doctors and researchers are facing a shortage of critical orthopedic devices. COVID-19 impacted the delay in the patient's treatment and significantly impacted the bones and joint surgeries. A decrease in the market value of orthopedic bone cement has been recorded in 2020, backed by the decline in road accidents and other causes that have impacted the market growth globally. Therefore, the demand for orthopedic bone cement decreased amid the COVID-19 pandemic, declining sales in 2020.

The global orthopedic bone cement market report would provide an access to approximately 61 market data tables, 53 figures and 170 pages